Adverse Events of Oral GLP-1 Receptor Agonist (Semaglutide Tablets): A Real-World Study Based on FAERS from 2019 to 2023

Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have attracted much attention because of their significant hypoglycemic and weight-loss effects. Previous preparations can only be subcutaneously injected. Oral administration of GLP-1RAs semaglutide helps to broaden treatment options...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes therapy 2024-08, Vol.15 (8), p.1717-1733
Hauptverfasser:	Xiong, Si, Gou, Ruoyu, Liang, Xudong, Wu, Hao, Qin, Shuitao, Li, Bing, Luo, Changjun, Chen, Junan
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse and side effects Analysis Antidiabetics Cardiology Care and treatment Complications and side effects Data mining Diabetes Drugs Endocrinology Gallbladder diseases Gastrointestinal diseases GLP-1 receptor agonists Internal Medicine Medicine Medicine & Public Health Metabolism Methods Neural networks Original Research Rankings Type 2 diabetes Weight loss
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!